Research Article

Association of ADRB2 rs1042713 with Obesity and Obesity-Related Phenotypes and Its Interaction with Dietary Fat in Modulating Glycaemic Indices in Malaysian Adults

Table 4

Differences in means (±SE) between ADRB2 rs1042713 gene variants in anthropometric, biochemical, and dietary parameters in obese and nonobese groups.

ADRB2 rs1042713 (dominant model)
Obese ()Nonobese ()

General characteristicsAA ()AG + GG () valueAA ()AG + GG () value
Age (years)47.8±2.042.8±1.50.03840.0 ± 2.739.7 ± 1.30.958
1Weight (kg)76.0 ± 2.081.2 ± 2.30.09757.9 ± 1.957.4 ± 1.00.957
1Height (cm)157.7 ± 1.7157.7 ± 1.00.688158.1 ± 1.5157.9 ± 0.80.871
1BMI (kg/m2)30.5 ± 0.532.4 ± 0.60.08623.0 ± 0.623.0 ± 0.30.936
1WC (cm)97.6 ± 2.299.4 ± 1.60.17368.6 ± 3.768.6 ± 2.00.899
1WHR0.90 ± 0.010.93 ± 0.010.1170.87 ± 0.010.87 ± 0.010.728
1Muscle mass (kg)24.0 ± 0.924.4 ± 0.70.52520.9 ± 1.020.9 ± 0.60.941
1Fat mass (kg)32.3 ± 1.236.6 ± 1.40.06519.2 ± 1.019.5 ± 0.60.887
1Fat-free mass (kg)43.8 ± 1.644.6 ± 1.20.47538.6 ± 1.637.9 ± 0.70.678
1Percent body fat (%)42.5 ± 1.244.8 ± 0.70.11033.3 ± 1.333.8 ± 0.80.683
1Systolic BP (mmHg)124.0 ± 3.6124.0 ± 2.00.712122.6 ± 5.0119.6 ± 2.30.587
1Diastolic BP (mmHg)81.0 ± 2.381.5 ± 1.30.53581.9 ± 2.779.2 ± 1.80.588
1Pulse rate (bpm)75.7 ± 2.576.1 ± 1.30.94875.1 ± 4.577.9 ± 2.00.556

Blood biochemical parametersAA ()AG + GG () valueAA ()AG + GG () value
2Fasting glucose (mmol/L)5.1 ± 0.25.3 ± 0.30.5095.0 ± 0.35.2 ± 0.30.561
2Fasting insulin (uU/mL)7.74 ± 1.611.2 ± 1.30.20911.7 ± 3.77.5 ± 1.40.361
2HOMA-IR1.9 ± 0.52.8 ± 0.30.1762.9 ± 1.02.2 ± 0.70.494
2Total cholesterol (mmol/L)5.0±0.25.7±0.10.0115.4 ± 0.35.6 ± 0.20.942
2Triglyceride (mmol/L)1.2 ± 0.21.4 ± 0.10.0831.7 ± 0.41.4 ± 0.10.983
2HDL cholesterol (mmol/L)1.6 ± 0.11.5 ± 0.10.7911.5 ± 0.11.6 ± 0.10.636
2LDL cholesterol (mmol/L)2.9±0.23.6±0.10.0083.3 ± 0.43.3 ± 0.20.650
2Total cholesterol/HDL cholesterol3.4±0.23.9±0.10.0483.7 ± 0.33.7 ± 0.20.650
2hsCRP (mg/L)5.2 ± 1.58.8 ± 1.40.0592.2 ± 0.52.9 ± 0.50.750

Dietary parametersAA ()AG + GG () valueAA ()AG + GG () value
3Total energy intake (kcal)2145.5 ± 108.02065.6 ± 41.70.7661897.5 ± 53.61867.5 ± 47.40.836
4Actual total carbohydrate intake (g)272.3 ± 20.7259.4 ± 7.20.967237.8 ± 13.1234.0 ± 11.00.625
4Actual total protein intake (g)75.1 ± 5.377.1 ± 3.10.98272.8 ± 5.370.0 ± 3.20.276
4Actual total dietary fat intake (g)90.2 ± 5.584.7 ± 3.10.81077.1 ± 4.177.7 ± 2.60.817
4Percentage energy from carbohydrate (%)46.9 ± 1.846.9 ± 1.20.99546.8 ± 2.147.7 ± 1.30.520
4Percentage energy from protein (%)13.8 ± 0.614.9 ± 0.50.79915.5 ± 1.214.4 ± 0.70.181
4Percentage energy from dietary fat (%)37.9 ± 1.936.4 ± 1.00.74436.4 ± 1.536.8 ± 1.10.968
4SFA (%TE)7.0 ± 1.07.6 ± 0.50.5147.0 ± 0.88.7 ± 0.60.307
4MUFA (%TE)11.8 ± 1.110.3 ± 0.60.33911.8 ± 1.112.1 ± 0.60.895
4PUFA (%TE)8.0±0.85.6±0.40.0366.5 ± 1.17.0 ± 0.60.523
4Trans fat (%TE)0.1 ± 0.010.1 ± 0.040.1090.1 ± 0.030.1 ± 0.020.497
4Dietary cholesterol (%TE)88.8 ± 14.0108.3 ± 10.50.987111.4 ± 22.9109.7 ± 16.10.471

One-way analysis of covariance was performed to determine the differences between means between gene variants in anthropometric, biochemical, and dietary parameters in obese and nonobese participants, after adjusting for covariates in different model 1age, gender, physical activity status, smoking status, and alcohol consumption; 2model1 + BMI, WC, body fat mass, and body fat percent; 3model1 + BMI; and 4model3 + total energy intake. was considered significant. HOMA-IR: homeostatic model assessment-insulin resistance; HDL: high-density lipoprotein; LDL: low-density lipoprotein; hsCRP: high-sensitivity C-reactive protein; SFA: saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; % TE: percentage of total energy intake.